Morgan Stanley has shifted its view on Affirm Holdings Inc (NASDAQ:AFRM), moving the stock from Overweight to Equal-weight and taking it off the bank's top pick roster. The change reflects the firm's assessment that the market now appropriately values the company's progress, and that the recent rebound in the share price has narrowed upside relative to risk.
The investment bank left its $79 price target intact. That target equates to roughly 23 times Morgan Stanley's fiscal year 2028 GAAP earnings per share estimate of $3.37. Separately, the firm noted the stock currently trades at about 22 times the FY28 GAAP EPS projection, compared with an implied 21 times multiple when the firm issued its prior outlook in February.
Analysts at Morgan Stanley increased their FY28 GAAP EPS estimate to $3.37 from $2.95 in early February, a rise of 14 percent. The firm highlighted that many of the uncertainties that prompted an earlier upgrade have been largely addressed. Specifically, it pointed to improved durability in gross merchandise volume (GMV), successful execution on funding, stronger credit performance and more stable unit economics.
Those operational improvements fed into Morgan Stanley's conclusion that the company's risk/reward profile is now more balanced. The brokerage identified three central drivers behind this reassessment: the resolution of questions around growth durability, demonstrated funding and credit execution, and diminished worries over unit economics. Importantly, the bank emphasized that the change in recommendation is a valuation-driven decision rather than an expression of structural doubt about the business model.
Management, Morgan Stanley said, remains best-in-class and buy now, pay later (BNPL) continues to win share, according to the firm's note. At the same time, the bank cautioned that investors are likely to assign a through-the-cycle multiple nearer to 20 times earnings, meaning that continued upward movement in the stock will require meaningful incremental earnings revisions to sustain investor sponsorship.
Market action and peer analyst coverage showed additional signs of confidence in Affirm's trajectory. The company agreed a renewed and expanded forward-flow arrangement with CPP Investments that will see $1.7 billion committed to purchasing the firm's installment loans. Following operational updates and market moves, Susquehanna and Compass Point increased their price targets for the company, while William Blair maintained an Outperform rating.
While the bank's tone toward Affirm has become more neutral from an investment recommendation standpoint, the underlying message is that many of the operational risks that weighed on the name earlier have eased. The change highlights the interplay between tangible business progress and market-implied valuation, underscoring that improved fundamentals do not automatically translate into a buy recommendation when prices have already moved materially.
Key points
- Morgan Stanley downgraded Affirm from Overweight to Equal-weight and removed it from its top pick list due to valuation after a sizable rally.
- The firm kept a $79 price target, implying roughly 23 times FY28 GAAP EPS of $3.37, and raised its FY28 EPS estimate by 14% from early February levels.
- Operational concerns around GMV durability, funding execution, credit performance and unit economics have largely been resolved, according to the bank.
Risks / uncertainties
- Valuation sensitivity - investors assigning a lower through-the-cycle multiple (near 20x) could limit upside absent further earnings revisions.
- Dependency on continued funding execution and credit performance to support further upward revisions to earnings estimates.